Company / Cash per Share
Senti Biosciences Holdings, Inc. Cash per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.40
FY2025
5-year range
$0.83 / $19.39
FY2022-FY2025
Trend
-67.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.83 to $3.40 over the past 2 years.
Based on SEC 10-K filings.
3.40 in FY2025 with a 3-year CAGR of -44.0%.
Improved from $0.83 to $3.40 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -44.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 67.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.40 | -67.8% |
| FY2024 | $10.56 | +1175.3% |
| FY2023 | $0.83 | -95.7% |
| FY2022 | $19.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026